Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Marker Therapeutics (MRKR) Debt Ratio (2016 - 2023)

Marker Therapeutics (MRKR) has disclosed Debt Ratio for 7 consecutive years, with 0.0 as the latest value for Q1 2023.

  • On a quarterly basis, Debt Ratio changed N/A to 0.0 in Q1 2023 year-over-year; TTM through Mar 2023 was 0.0, a N/A change, with the full-year FY2022 number at 0.07, changed N/A from a year prior.
  • Debt Ratio was 0.0 for Q1 2023 at Marker Therapeutics, down from 0.07 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.15 in Q2 2022 to a low of 0.0 in Q4 2019.
  • A 3-year average of 0.04 and a median of 0.0 in 2019 define the central range for Debt Ratio.
  • Biggest YoY gain for Debt Ratio was 15.19% in 2019; the steepest drop was 93.65% in 2019.
  • Marker Therapeutics' Debt Ratio stood at 0.0 in 2019, then skyrocketed by 10761.17% to 0.07 in 2022, then crashed by 95.2% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for MRKR's Debt Ratio are 0.0 (Q1 2023), 0.07 (Q4 2022), and 0.12 (Q3 2022).